The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
പരിശീലന ദൗത്യത്തിനിടെ യുഎഇ സായുധ സേനയിലെ രണ്ട് അംഗങ്ങൾക്ക് വീരമൃത്യു
2 members of UAE Armed Forces martyred during training mission
Dubai to host inaugural RailX conference in 2027
UAE President welcomes King of Jordan, discusses regional issues
Sheikh Abdullah holds bilateral talks with regional counterparts
Dubai records nearly 7 million international visitors in 2026
H.H. Sheikh Hamdan selects first recipient of Mohammed bin Rashid leadership medal
Gargash says meeting with Iranian President reflects UAE's 'deterrence and diplomacy'
